Pathways Picks April 21: Taiwan Regs, EU Standards, FDA Updates, and More

article image

In this week’s roundup: “Next Picks” on upcoming Taiwan device regulations and the FDA commissioner nomination watch; Europe updates in the lead up to MDR; user fee negotiation news and more from the FDA review front; Medicare, MCIT, and more to watch on UK NICE, software deregulation, UDI, China, and Italy.

In this week’s Picks, first a look ahead on Taiwan regulations and a mea culpa on FDA commissioner predictions, followed by reports from Europe, FDA, Medicare, and more in the medtech policy space.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: